Total Payments
$1,676
2024 Payments
$180.60
Companies
23
Transactions
105
Medicare Patients
5,558
Medicare Billing
$191,388
Payment Breakdown by Category
Food & Beverage$1,584 (94.5%)
Education$92.16 (5.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,584 | 101 | 94.5% |
| Education | $92.16 | 4 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $317.43 | 19 | $0 (2023) |
| Novo Nordisk Inc | $285.71 | 21 | $0 (2024) |
| AbbVie Inc. | $159.08 | 14 | $0 (2023) |
| Eisai Inc. | $100.46 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $99.33 | 6 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $73.86 | 5 | $0 (2022) |
| Amgen Inc. | $72.39 | 5 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $71.99 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $63.35 | 5 | $0 (2018) |
| Lilly USA, LLC | $60.73 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $180.60 | 7 | Eisai Inc. ($100.46) |
| 2023 | $220.24 | 10 | Averitas Pharma Inc. ($60.25) |
| 2022 | $462.69 | 30 | PFIZER INC. ($158.50) |
| 2020 | $83.46 | 6 | Allergan, Inc. ($26.78) |
| 2019 | $229.21 | 13 | Ethicon US, LLC ($53.15) |
| 2018 | $221.23 | 19 | Novo Nordisk Inc ($113.67) |
| 2017 | $278.92 | 20 | Merck Sharp & Dohme Corporation ($50.92) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $39.75 | General |
| Category: Neurology | ||||||
| 10/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Neurology | ||||||
| 07/18/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 07/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: Neurology | ||||||
| 04/10/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 01/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Respiratory | ||||||
| 09/19/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $60.25 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/16/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes | ||||||
| 05/16/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.13 | General |
| Category: Insulin Pump | ||||||
| 05/10/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/05/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING, PAXLOVID | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: WOMENS HEALTH | ||||||
| 03/23/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/15/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Diabetes | ||||||
| 02/07/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Diabetes | ||||||
| 11/29/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/17/2022 | PFIZER INC. | MYFEMBREE (Drug) | Education | In-kind items and services | $23.04 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 11/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.11 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 403 | 404 | $30,800 | $27,323 |
| 2022 | 8 | 580 | 580 | $24,815 | $22,622 |
| 2021 | 16 | 4,364 | 4,424 | $168,181 | $123,719 |
| 2020 | 8 | 211 | 295 | $54,431 | $17,724 |
Total Patients
5,558
Total Services
5,703
Medicare Billing
$191,388
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 112 | 112 | $16,800 | $14,390 | 85.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 75 | 75 | $5,590 | $5,371 | 96.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 112 | 112 | $5,040 | $4,315 | 85.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 82 | 83 | $2,490 | $2,399 | 96.3% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 22 | 22 | $880.00 | $847.66 | 96.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 91 | 91 | $6,370 | $6,237 | 97.9% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 147 | 147 | $5,880 | $5,288 | 89.9% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 140 | 140 | $5,600 | $4,987 | 89.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 105 | 105 | $3,150 | $2,835 | 90.0% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 33 | 33 | $1,320 | $1,175 | 89.1% |
| 0003A | Adm sarscov2 30mcg/0.3ml 3rd | Office | 2022 | 26 | 26 | $1,040 | $943.30 | 90.7% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 24 | 24 | $960.00 | $861.53 | 89.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 14 | 14 | $495.00 | $294.70 | 59.5% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 1,485 | 1,484 | $54,928 | $45,225 | 82.3% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 1,475 | 1,477 | $35,560 | $27,758 | 78.1% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 659 | 658 | $26,356 | $24,116 | 91.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 133 | 133 | $9,310 | $8,680 | 93.2% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 106 | 106 | $4,240 | $3,885 | 91.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 168 | 168 | $5,040 | $2,626 | 52.1% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 97 | 97 | $3,840 | $2,520 | 65.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 43 | $7,452 | $2,399 | 32.2% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 20 | 47 | $4,874 | $1,582 | 32.5% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 94 | 94 | $1,880 | $1,469 | 78.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 15 | 17 | $2,710 | $898.79 | 33.2% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 37 | 37 | $1,480 | $759.61 | 51.3% |
About Dr. David Bender, MD
Dr. David Bender, MD is a Family Medicine healthcare provider based in Grafton, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891892626.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Bender, MD has received a total of $1,676 in payments from pharmaceutical and medical device companies, with $180.60 received in 2024. These payments were reported across 105 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,584).
As a Medicare-enrolled provider, Bender has provided services to 5,558 Medicare beneficiaries, totaling 5,703 services with total Medicare billing of $191,388. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Grafton, WV
- Active Since 09/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891892626
Products in Payments
- Ozempic (Drug) $131.02
- ELIQUIS (Drug) $113.46
- Leqembi (Drug) $100.46
- ENTRESTO (Drug) $99.33
- MYFEMBREE (Drug) $92.16
- VRAYLAR (Drug) $71.42
- KEVEYIS (Drug) $63.47
- DALVANCE (Drug) $62.41
- QUTENZA (Drug) $60.25
- FARXIGA (Drug) $56.77
- Prolia (Biological) $54.00
- LINX Reflux Management System (Device) $53.15
- QULIPTA (Drug) $52.03
- TRADJENTA (Drug) $46.65
- Vascepa (Drug) $44.33
- LYRICA (Drug) $37.21
- Rybelsus (Drug) $36.54
- TRULICITY (Drug) $31.49
- PREVNAR - 13 (Biological) $29.13
- ZOSTAVAX (Biological) $27.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Grafton
Gloria Jackson, M.d, M.D
Family Medicine — Payments: $5,395
Family Medicine $5,395
John Hollingsworth, M.d, M.D
Family Medicine — Payments: $2,211
Family Medicine $2,211
Dr. Michael Hess, M.d, M.D
Family Medicine — Payments: $2,186
Family Medicine $2,186
Dr. Jennifer Shaw, M.d, M.D
Family Medicine — Payments: $2,164
Family Medicine $2,164
Mr. Gregory Selasky, Ms, P.a.-C, MS, P.A.-C
Family Medicine — Payments: $1,974
Family Medicine $1,974
Dr. Matthew Viscito, M.d, M.D
Family Medicine — Payments: $1,414
Family Medicine $1,414